1960
DOI: 10.1111/j.1476-5381.1960.tb01247.x
|View full text |Cite
|
Sign up to set email alerts
|

The Bronchoconstrictor Action of Bradykinin in the Guinea‐pig

Abstract: Bradykinin was found to be a potent bronchoconstrictor agent in the guinea-pig anaesthetized with urethane. This action was not affected by vagotomy, or by treatment of the animal with mepyramine, atropine, lysergic acid diethylamide, or cortisone. Adrenaline and isoprenaline suppressed the bronchoconstrictor responses to bradykinin and histamine. Small doses of acetylsalicylic acid, however, suppressed only that to bradykinin. Bradykinin also produced bronchoconstriction in the isolated perfused lungs of the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
37
1
1

Year Published

1961
1961
2000
2000

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 94 publications
(40 citation statements)
references
References 6 publications
1
37
1
1
Order By: Relevance
“…Ungar (1952) has shown that it is possible to explain the anti-inflammatory action of the antipyretic-analgesic class of drugs on the basis of their anti-fibrinolysin activity, and it could be postulated that the ability of the various analgesic-antipyretic drugs capable of inhibiting formaldehyde-induced inflammation in the mouse foot is due to their anti-fibrinolysin action. Recently, however, Collier, Holgate, Schachter & Shorley (1960) have shown that salicylate is capable of completely inhibiting the action of bradykinin on bronchial smooth muscle in vivo. Since this peptide also causes an increase in capillary permeability, it is possible that the inhibition of formaldehyde-induced inflammation which we have observed is due to an inhibition of the action of bradykinin released by the damaged tissues.…”
Section: Discussionmentioning
confidence: 99%
“…Ungar (1952) has shown that it is possible to explain the anti-inflammatory action of the antipyretic-analgesic class of drugs on the basis of their anti-fibrinolysin activity, and it could be postulated that the ability of the various analgesic-antipyretic drugs capable of inhibiting formaldehyde-induced inflammation in the mouse foot is due to their anti-fibrinolysin action. Recently, however, Collier, Holgate, Schachter & Shorley (1960) have shown that salicylate is capable of completely inhibiting the action of bradykinin on bronchial smooth muscle in vivo. Since this peptide also causes an increase in capillary permeability, it is possible that the inhibition of formaldehyde-induced inflammation which we have observed is due to an inhibition of the action of bradykinin released by the damaged tissues.…”
Section: Discussionmentioning
confidence: 99%
“…The details of the modifications that result in simplification and improved sensitivity fi-Adrenoceptor blockade and air overflow are described in the Appendix to this paper. Increases in air overflow were produced by intravenous injections of methacholine or histamine, and rapid recovery was effected by occluding the overflow tube for a time, as suggested by Collier, Holgate, Schachter & Shorley (1960). The animals were always bilaterally vagotomized as this improved the regularity of response.…”
Section: Methodsmentioning
confidence: 99%
“…One possibility that we have considered is that these compounds inhibit the activity of a plasma kinin-forming enzyme system or act as antagonists of plasma kinin. Collier, Holgate, Schachter & Shorley (1960) have reported that salicylates inhibit the bronchoconstrictor action of bradykinin, and we have shown (Northover & Subramanian, 1961b) that salicylates and other analgesic-antipyretic drugs inhibit plasma kallikrein, which is a plasma kinin-forming enzyme. There are two reasons for thinking, however, that plasma kinin is not an important mediator in the reaction of the mouse foot to formaldehyde.…”
Section: Discussionmentioning
confidence: 99%